A low-cost blood pressure medicine is showing real promise for people recovering from a stroke, especially those who still cannot get their numbers down with standard care. In a new trial, adding spironolactone helped far more patients reach the recommended blood pressure target, raising fresh attention on a treatment that is already familiar, inexpensive, and widely used.
The study, called the REDUCE trial, tested whether spironolactone, often described as a water pill, could improve blood pressure control after a stroke. Researchers presented the findings at the American Heart Association’s Scientific Sessions in Chicago, and the results pointed to a clear difference between the two treatment groups.
Some participants added spironolactone to their regular post-stroke regimen, while others stayed with usual care. Over the next six months, the research team monitored blood pressure at home to see whether the added medication made a measurable difference in daily life.
By the three-month mark, the top blood pressure number had dropped by nearly eight points more in the spironolactone group than in the group receiving usual care. That average came out to about 126 versus 133, which is a meaningful gap when the goal is to keep pressure under control after a stroke.
Even more striking, 52% of the patients taking spironolactone reached the recommended goal of less than 130/80. In the usual care group, only 30% hit that target, a spread that suggests the medication could fill an important gap for survivors who remain above goal despite treatment.
That matters because blood pressure control is one of the biggest levers in preventing another stroke. Dr. Jordana Cohen, a co-lead author of the study, said many survivors still struggle to reach the right range after the first event, even though that is one of the most important steps in lowering future risk.
She also noted that adding spironolactone produced a drop in blood pressure that could potentially reduce the chance of another stroke or heart attack. Still, the study focused on blood pressure itself, not whether people actually had fewer repeat events down the line.
Dr. Alfred Joshua, a California-based emergency physician who was not involved in the research, said the findings are encouraging but not final. The big question is still whether better blood pressure numbers will translate into fewer repeat strokes, and that answer will take larger studies to prove.
Spironolactone works by helping the body shed extra salt and water, which can bring pressure down. It also affects potassium levels, which is why patients taking it need monitoring and why doctors pay close attention to kidney function and other medications.
That safety piece is not small. High potassium can creep up without obvious symptoms, and the risk is higher for people with kidney problems or for those already taking certain drugs or supplements that affect potassium balance.
The medication can also lower blood pressure enough to make some people feel lightheaded or dizzy. For stroke survivors already trying to stay steady and avoid complications, that means careful follow-up matters just as much as the prescription itself.
The trial was not huge, and that is worth keeping in mind. It ended early with 160 participants instead of the planned 200, and not every patient had a full set of readings at the three-month check-in.
There was another wrinkle too, since people in the spironolactone group were taking slightly more blood pressure medicines overall. That makes the results interesting, but it also means the findings should be read as an encouraging sign rather than a done deal.
Even with those limits, the numbers add fuel to a simple idea: getting blood pressure down after a stroke is still one of the clearest ways to protect the brain and heart. For patients who are stuck above target, spironolactone may give doctors another tool that is cheap, familiar, and surprisingly effective.
For many survivors, the next step may be as straightforward as showing home readings to a clinician and asking whether this medication fits their situation. When a small pill can move the numbers this much, that conversation can carry real weight.
